This Institute came into existence on 1st April,1976 when the India Centre of JALMA was officially handed over to the Govt. of India and subsequently to the Indian Council of Medical Research. This was named as Central JALMA Institute for Leprosy in 1976 and has been renamed as 'National Jalma Institute of Leprosy and other Mycobacterial Diseases' in 2005 to reflect its broader research areas. This Institute was originally established as 'India Centre of JALMA' in 1966 and was managed by a Tokyo based voluntary organisation -JALMA (Japanese Leprosy Mission for Asia). This Institute is one of the fine examples of international human links and compassion for each other. The Institute has completed 37 years of its existence under ICMR. The Institute has a major thrust on leprosy (40%), relevant areas of tuberculosis and other mycobacteriosis (40%), HIV (10%) and Filariasis etc (10%). During its existence as a research Institute under ICMR the scientists of the Institute have continued to contributed on almost all aspects of leprosy, several cutting edge areas of tuberculosis ( DNA fingerprinting methods, drug resistance etc), selected areas of HIV-AIDs and has now made forays in to related problems like filariasis.

The main objectives of the Institute are to develop and standardise techniques of investigation for diagnosis, treatment and assessment for better management of leprosy with ultimate goal of eradication of this disease by helping the National Leprosy Eradication Programme (NLEP).

LEPROSY
•Understanding the disease better using electrophysiological, immunological, molecular and electron-microscopic tools.
•Developing better technologies for diagnosis using immunological, molecular and in-situ techniques.
•Viability methods using foot pad, ATP, molecular methods for drug resistance.
•Transmission: Epidemiological, molecular approaches.
•Improved regimens, new regimens, improved surgical methods, drug action, kinetics etc.
TUBERCULOSIS AND OTHER MYCOBACTERIAL INFECTIONS
•Techniques for DNA fingerprinting: Ribotyping; application studies using other genotypic methods.
•Drug resistance: Molecular mechanisms, probes, microarray based approaches; New herbal drugs.
•Therapy, Vaccines
•Animal Studies: Immunomodulation; drugs.
•HIV / AIDS:
•Relationship between HIV-TB, HIV and Leprosy.
•Clinical course of disease.
•Filariasis
•Co-endemicity of filariasis with leprosy etc

https://www.jalma-icmr.org.in/interface/scientists.htm

https://www.jalma-icmr.org.in/dynamic/Awards.asp

https://www.jalma-icmr.org.in/dynamic/research-profile.htm
https://www.jalma-icmr.org.in/dynamic/research-areas.asp